Taiwanese Pharmaceuticals & Biotech Strong Balance Sheet Stocks

PhytoHealth

Market Cap: NT$2.9b

Researches, develops, manufactures, and sells medicines, cosmetics, Class B medicines, complementary foods, and other related products in Taiwan.

Maxigen Biotech

Market Cap: NT$3.6b

Researches, develops, produces, and sells implantable medical devices and cosmetic products in Taiwan, America, Europe, rest of Asia, and internationally.

Intelligene

Market Cap: NT$8.4b

Engages in the research and development of RNA gene therapy drugs in Taiwan and Australia.

Orient Pharma

Market Cap: NT$6.5b

Engages in the development of new drugs in Taiwan and internationally.

Holy Stone Healthcare

Market Cap: NT$1.1b

Develops and sells hyaluronic acid-related therapeutic products in Taiwan.

Eusol BiotechLtd

Market Cap: NT$1.1b

Focuses on research and development of new drugs for the treatment of nerve injuries.

TCM Biotech International

Market Cap: NT$10.7b

A biotech company, engages in the research and development of drugs for liver diseases.

Bonraybio

Market Cap: NT$4.3b

A development stage company, manufactures medical instruments and solutions for the male infertility market.

StemCyte International

Market Cap: NT$5.4b

A biotechnology company, develops cord blood–based cell therapies in the United States and Taiwan.

Shine-On BioMedicalLtd

Market Cap: NT$3.5b

Research, develops, and manufactures anti-cancer related drug products.

Savior Lifetec

Market Cap: NT$5.9b

A specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations.

CHO Pharma

Market Cap: NT$5.6b

Engages in research and development of biotechnology in Taiwan.

HeXun Biosciences

Market Cap: NT$2.7b

Engages in the research and development of stem cell drug development and cardiovascular disease treatments in Taiwan.

PharmaEngine

Market Cap: NT$9.3b

A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.

Johnson Chemical Pharmaceutical Works

Market Cap: NT$2.5b

Johnson Chemical Pharmaceutical Works Co., Ltd.

BIONET Therapeutics

Market Cap: NT$3.6b

A biopharmaceutical company, develops cell therapy products and drug development for acute and severe diseases.

Advagene Biopharma

Market Cap: NT$1.9b

Engages in the research and development of vaccine technology and related products in Taiwan.

Anya Biopharm

Market Cap: NT$1.9b

A pharmaceutical company, develops platforms for the delivery of oral peptides in Taiwan, rest of Asia, and Europe.

EirGenix

Market Cap: NT$18.5b

Operates as a contract development and manufacturing company in Taiwan and internationally.

Formosa Pharmaceuticals

Market Cap: NT$4.1b

A clinical stage biopharmaceutical company, engages in developing drug candidates for ophthalmology, oncology, and anti-infectives in Taiwan.

Sunhawk Vision Biotech

Market Cap: NT$3.3b

Operates as a drug development company that develops microRNA therapeutic eye drops.

Alar Pharmaceuticals

Market Cap: NT$17.9b

A drug development company, focuses on developing long-acting release drug products for CNS disorders and chronic diseases in Taiwan.

Vetnostrum Animal Health

Market Cap: NT$2.6b

Engages in the import, manufacture, and sale of animal medicines, health food, feed additives, and feed.

TaiwanJ Pharmaceuticals

Market Cap: NT$616.9m

A specialty pharmaceutical company, develops and commercializes small molecules for chronic organ inflammation of metabolic, autoimmune, and infectious etiologies in Taiwan.

ScinoPharm Taiwan

Market Cap: NT$17.1b

Research and develops, produces, and sells active pharmaceutical ingredients (API) to pharmaceutical companies in Taiwan, rest of Asia, Europe, the America, and internationally.

Oneness Biotech

Market Cap: NT$27.8b

Engages in the research, development, and sale of new drugs, pharmaceuticals, and health products in Taiwan.

Ever Supreme Bio Technology

Market Cap: NT$13.5b

Engages in the research, development, and manufacture of drug products related to human mesenchymal stem cells and immune cells in Taiwan.

Sinew Pharma

Market Cap: NT$2.8b

A biopharmaceutical company, focuses on the research, development, and sale of drugs for the treatment of hepatotoxicity-free acetaminophen and fatty liver diseases.

Syngen BiotechLtd

Market Cap: NT$3.3b

Engages in the research, development, manufacturing, and sale of microbial pharmaceutical raw materials, biological pesticides, fertilizers and biochemical nutritional products, and preventive medicines in Taiwan, China, and internationally.

Medigen Vaccine Biologics

Market Cap: NT$11.8b

A biotechnology drug company, engages in the research, development, and wholesale of vaccines and biopharmaceuticals, and medical devices in Taiwan.

Pharmosa Biopharm

Market Cap: NT$5.4b

A biotechnology company, focuses on developing drugs in Taiwan.

ACRO Biomedical

Market Cap: NT$4.1b

Develops medical-grade regenerative biomaterials.

TaiRx

Market Cap: NT$2.2b

Focuses on the development and commercialization of therapeutics for the treatment of cancer and other diseases.

Standard Chemical & Pharmaceutical

Market Cap: NT$10.8b

Manufactures and sells pharmaceutical products in Taiwan and internationally.

PharmaEssentia

Market Cap: NT$268.1b

A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.

TWi Biotechnology

Market Cap: NT$2.4b

A clinical-stage biopharmaceutical company, develops and sells drugs for innate immunity-related diseases in Taiwan.